Analysis of human plasma metabolites across different liquid chromatography/mass spectrometry platforms: Cross-platform transferable chemical signatures (Rapid Commun. Mass Spectrom., (2016), 30, (581-593), 10.1002/rcm.7475);Analysis of human plasma metabolites across different liquid chromatography/mass spectrometry platforms: Cross-platform transferable chemical signatures

Rapid Communications in Mass Spectrometry

Volumn 30, Issue 5, 2016, Pages 581-593

  Telu, Kelly H ^a   Yan, Xinjian ^a   Wallace, William E ^a   Stein, Stephen E ^a   Simõn Manso, Yamil ^a  

^a NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; DATA HANDLING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIBRARIES; SPECTROMETRY;

CHEMICAL SIGNATURES; CROSS-PLATFORM; HUMAN PLASMAS; LIQUID CHROMATOGRAPHY - MASS SPECTROMETRIES; MASS SPECTRAL LIBRARIES; METABOLITE PROFILES; NON-TARGETED; PLASMA METABOLITES; SPECTRA'S; TANDEM MASS;

METABOLITES;

CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; METABOLOME; METABOLOMICS; PLASMA; PROCEDURES; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; HUMANS; METABOLOME; METABOLOMICS; PLASMA; TANDEM MASS SPECTROMETRY;

EID: 84957052936     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.7773     Document Type: Erratum

References (51)

1. G. J. Patti, O. Yanes, G. Siuzdak,. Innovation: Metabolomics: the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 2012, 13, 263.
2. O. Yanes, R. Tautenhahn, G. J. Patti, G. Siuzdak,. Expanding coverage of the metabolome for global metabolite profiling. Anal. Chem. 2011, 83, 2152.
3. N. Psychogios, D. D. Hau, J. Peng, A. C. Guo, R. Mandal, S. Bouatra, I. Sinelnikov, R. Krishnamurthy, R. Eisner, B. Gautam,. The human serum metabolome. PLoS One 2011, 6, e16957.
4. N. L. Kuehnbaum, P. Britz-McKibbin,. New advances in separation science for metabolomics: resolving chemical diversity in a post-genomic era. Chem. Rev. 2013, 113, 2437.
5. J. M. Buscher, D. Czernik, J. C. Ewald, U. Sauer, N. Zamboni,. Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. Anal. Chem. 2009, 81, 2135.
6. A. A. Vaughan, W. B. Dunn, J. W. Allwood, D. C. Wedge, F. H. Blackhall, A. D. Whetton, C. Dive, R. Goodacre,. Liquid chromatography-mass spectrometry calibration transfer and metabolomics data fusion. Anal. Chem. 2012, 84, 9848.
7. O. Beckonert, H. C. Keun, T. M. Ebbels, J. Bundy, E. Holmes, J. C. Lindon, J. K. Nicholson,. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protocols 2007, 2, 2692.
8. K. A. Lawton, A. Berger, M. Mitchell, K. E. Milgram, A. M. Evans, L. Guo, R. W. Hanson, S. C. Kalhan, J. A. Ryals, M. V. Milburn,. Analysis of the adult human plasma metabolome. Pharmacogenomics 2008, 9, 383.
9. A. D. Patterson, O. Maurhofer, D. Beyoʇlu, C. Lanz, K. W. Krausz, T. Pabst, F. J. Gonzalez, J.-F. Dufour, J. R. Idle,. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res. 2011, 71, 6590.
10. S. Urayama, W. Zou, K. Brooks, V. Tolstikov,. Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun. Mass Spectrom. 2010, 24, 613.
11. L. Fan, W. Zhang, M. Yin, T. Zhang, X. Wu, H. Zhang, M. Sun, Z. Li, Y. Hou, X. Zhou, G. Lou, K. Li,. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform. Acta Oncol. 2012, 51, 473.
12. A. Sreekumar, L. M. Poisson, T. M. Rajendiran, A. P. Khan, Q. Cao, J. Yu, B. Laxman, R. Mehra, R. J. Lonigro, Y. Li,. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457, 910.
13. X. M. Cai, J. Dong, L. J. Zou, X. Y. Xue, X. L. Zhang, X. M. Liang,. Metabonomic Study of Lung Cancer and the Effects of Radiotherapy on Lung Cancer Patients: Analysis of Highly Polar Metabolites by Ultraperformance HILIC Coupled with Q-TOF MS. Chromatographia 2011, 74, 391.
14. X. M. Cai, L. Zou, J. Dong, L. Zhao, Y. Wang, Q. Xu, X. Xue, X. Zhang, X. Liang,. Analysis of highly polar metabolites in human plasma by ultra-performance hydrophilic interaction liquid chromatography coupled with quadrupole-time of flight mass spectrometry. Anal. Chim. Acta 2009, 650, 10.
15. E. J. Want, G. O'Maille, C. A. Smith, T. R. Brandon, W. Uritboonthai, C. Qin, S. A. Trauger, G. Siuzdak,. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal. Chem. 2006, 78, 743.
16. S. Tulipani, R. Llorach, M. Urpi-Sarda, C. Andres-Lacueva,. Comparative analysis of sample preparation methods to handle the complexity of the blood fluid metabolome: When less is more. Anal.Chem. 2013, 85, 341.
17. S. J. Bruce, I. Tavazzi, V. Parisod, S. Rezzi, S. Kochhar, P. A. Guy,. Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. Anal. Chem. 2009, 81, 3285.
18. Y. Simõn-Manso, M. S. Lowenthal, L. E. Kilpatrick, M. L. Sampson, K. H. Telu, P. A. Rudnick, W. G. Mallard, D. W. Bearden, T. B. Schock, D. V. Tchekhovskoi, N. Blonder, X. Yan, Y. Liang, Y. Zheng, W. E. Wallace, P. Neta, K. W. Phinney, A. T. Remaley, S. E. Stein,. Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. Anal. Chem. 2013, 85, 11725.
19. G. Ballihaut, L. E. Kilpatrick, W. C. Davis,. Detection, identification, and quantification of selenoproteins in a candidate human plasma standard reference material. Anal. Chem. 2011, 83, 8667.
20. E. A. McGaw, K. W. Phinney, M. S. Lowenthal,. Comparison of orthogonal liquid and gas chromatography-mass spectrometry platforms for the determination of amino acid concentrations in human plasma. J. Chromatogr. A 2010, 1217, 5822.
21. J. L. Reiner, K. W. Phinney, J. M. Keller,. Determination of perfluorinated compounds in human plasma and serum Standard Reference Materials using independent analytical methods. Anal. Bioanal. Chem. 2011, 401, 2899.
22. O. Quehenberger, A. M. Armando, A. H. Brown, S. B. Milne, D. S. Myers, A. H. Merrill, S. Bandyopadhyay, K. N. Jones, S. Kelly, R. L. Shaner, C. M. Sullards, E. Wang, R. C. Murphy, R. M. Barkley, T. J. Leiker, C. R. Raetz, Z. Guan, G. M. Laird, D. A. Six, D. W. Russell, J. G. McDonald, S. Subramaniam, E. Fahy, E. A. Dennis,. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 2010, 51, 3299.
23. G. A. Gowda, F. Tayyari, T. Ye, Y. Suryani, S. Wei, N. Shanaiah, D. Raftery,. Quantitative analysis of blood plasma metabolites using isotope enhanced NMR methods. Anal. Chem. 2010, 82, 8983.
24. J. L. Prendergast, L. T. Sniegoski, M. J. Welch, K. W. Phinney,. Modifications to the NIST reference measurement procedure (RMP) for the determination of serum glucose by isotope dilution gas chromatography/mass spectrometry. Anal. Bioanal. Chem. 2010, 397, 1779.
25. K. W. Phinney, G. Ballihaut, M. Bedner, B. S. Benford, J. E. Camara, S. J. Christopher, W. C. Davis, N. G. Dodder, G. Eppe, B. E. Lang, S. E. Long, M. S. Lowenthal, E. A McGaw, K. E. Murphy, B. C Neslon, J. L. Prendergast, J. L. Reiner, C. A. Rimmer, L. C. Sander, M. M. Schantz, K. E. Sharpless, L. T. Sniegoski, S. S. C. Tai, J. B. Thomas, T. W. Vetter, M. J. Welch, S. A. Wise, L. J. Wood, W. F. Guthrie, C. R. Hagwood, S. D. Leigh, J. H. Yen, N. F. Zhang, M. Chaudhary-Webb, H. P. Chen, Z. Fazili, D. J. LaVoie, L. F. McCoy, S. S. Momin, N. Paladugula, E. C. Pendergrast, C. M. Pfeiffer, C. D. Powers, D. Rabinowitz, M. E. Rybak, R. L. Schleicher, B. M. H. Toombs, M. Xu, M. Zhang, A. L. Castle,. Development of a Standard Reference Material for metabolomics research. Anal. Chem. 2013, 85, 11732.
26. J. E. Elias, W. Haas, B. K. Faherty, S. P. Gygi,. Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations. Nat. Methods 2005, 2, 667.
27. C. A. Smith, E. J. Want, G. O'Maille, R. Abagyan, G. Siuzdak,. XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 2006, 78, 779.
28. R. Tautenhahn, C. Bottcher, S. Neumann,. Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics 2008, 9, 504.
29. E. J. W., a., T. M. D. E,., H. Paul Benton,. Correction of mass calibration gaps in liquid chromatography-mass spectrometry metabolomics data. Bioinformatics 2010, 26, 2488.
30. Available: http://peptide.nist.gov.
31. P. A. Rudnick, K. R. Clauser, L. E. Kilpatrick, D. V. Tchekhovskoi, P. Neta, N. Blonder, D. D. Billheimer, R. K. Blackman, D. M. Bunk, H. L. Cardasis, A. J. Ham, J. D. Jaffe, C. R. Kinsinger, M. Mesri, T. A. Neubert, B. Schilling, D. L. Tabb, T. J. Tegeler, L. Vega-Montoto, A. M. Variyath, M. Wang, P. Wang, J. R. Whiteaker, L. J. Zimmerman, S. A. Carr, S. J. Fisher, B. W. Gibson, A. G. Paulovich, F. E. Regnier, H. Rodriguez, C. Spiegelman, P. Tempst, D. C. Liebler, S. E. Stein,. Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses. Mol. Cell. Proteomics 2010, 9, 225.
32. W. A. Rutala, D. J. Weber,. Guideline for disinfection and sterilization in healthcare facilities. Centers for Disease Control (US), 2008.
33. P. L. Roberts, D. Lloyd,. Virus inactivation by protein denaturants used in affinity chromatography. Biologicals 2007, 35, 343.
34. D. Guillarme, D. T. Nguyen, S. Rudaz, J. L. Veuthey,. Method transfer for fast liquid chromatography in pharmaceutical analysis: application to short columns packed with small particle. Part I: isocratic separation. Eur. J. Pharm. Biopharm. 2007, 66, 475.
35. D. Guillarme, D. T. Nguyen, S. Rudaz, J. L. Veuthey,. Method transfer for fast liquid chromatography in pharmaceutical analysis: application to short columns packed with small particle. Part II: gradient experiments. Eur. J. Pharm. Biopharm. 2008, 68, 430.
36. NIST. Tandem Mass Spectral Library, 2014.
37. S. E. Stein,. Estimating probabilities of correct identification from results of mass spectral library searches. J. Am. Soc. Mass Spectrom. 1994, 5, 316.
38. S. E. Stein, D. R. Scott,. Optimization and testing of mass spectral library search algorithms for compound identification. J. Am. Soc. Mass Spectrom. 1994, 5, 859.
39. W. G. Mallard, N. R. Andriamaharavo, Y. A. Mirokhin, J. M. Halket, S. E. Stein,. Creation of libraries of recurring mass spectra from large data sets assisted by a dual-column workflow. Anal. Chem. 2014, 86, 10231.
40. W. E. Wallace, A. Srivastava, K. H. Telu, Y. Simõn-Manso,. Pairwise alignment of chromatograms using an extended Fisher-Rao metric. Anal. Chim. Acta 2014, 841, 10.
41. B. Iglewicz, D. Hoaglin,. How to detect and handle outliers, in The ASQC Basic References in Quality Control: Statistical Techniques, vol. 16, (Ed:, E. F. Mykytka,), 1993.
42. O. Hrydziuszko, M. R. Viant,. Missing values in mass spectrometry based metabolomics: an undervalued step in the data processing pipeline. Metabolomics 2012, 8, S161.
43. J. W. Dolan, L. R. Snyder, N. M. Djordjevic, D. W. Hill, T. G. Waeghe,. Reversed-phase liquid chromatographic separation of complex samples by optimizing temperature and gradient time; I. Peak capacity limitations. J. Chromatogr. A 1999, 857, 1.
44. H. G. Gika, E. Macpherson, G. A. Theodoridis, I. D. Wilson,. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 871, 299.
45. T. R. Sana, K. Waddell, S. M. Fischer,. A sample extraction and chromatographic strategy for increasing LC/MS detection coverage of the erythrocyte metabolome. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 871, 314.
46. A. Rafiei, L. Sleno,. Comparison of peak-picking workflows for untargeted liquid chromatography/high-resolution mass spectrometry metabolomics data analysis. Rapid Commun. Mass Spectrom. 2015, 29, 119.
47. F. Jentzmik, C. Stephan, M. Lein, K. Miller, B. Kamlage, B. Bethan, G. Kristiansen, K. Jung,. Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression. J. Urol. 2010, 185, 706.
48. C. Wagner, Z. Luka,. Sarcosine, folate metabolism and prostate cancer-Is there a link? J. Urol. 2010, 185, 385.
49. 2 in electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2015, 29, 629.
50. P. Neta, M. Farahani, Y. Simõn-Manso, Y. Liang, X. Yang, S. E. Stein,. Unexpected peaks in tandem mass spectra due to reaction of product ions with residual water in mass spectrometer collision cells. Rapid Commun. Mass Spectrom. 2014, 28, 2645.
51. J. C. Martin, M. Maillot, G. Mazerolles, A. Verdu, B. Lyan, C. Migne, C. Defoort, C. Canlet, C. Junot, C. Guillou, C. Manach, D. Jabob, D. J. Bouveresse, E. Paris, E. Pujos-Guillot, F. Jourdan, F. Giacomoni, F. Courant, G. Fave, G. Le Gall, H. Chassaigne, J. C. Tabet, J. F. Martin, J. P. Antignac, L. Shintu, M. Defernez, M. Philo, M. C. Alexandre-Gouaubau, M. J. Amiot-Carlin, M. Bossis, M. N. Triba, N. Stojilkovic, N. Banzet, R. Molinie, R. Bott, S. Goulitquer, S. Caldarelli, D. N. Rutledge,. Can we trust untargeted metabolomics? Results of the Metabo-ring Initiative, a large-scale, multi-instrument inter-laboratory study. Metabolomics 2015, 11, 807.